Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Viral Structure00:56

Viral Structure

63.9K
Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
63.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Chen et al. Elucidating the Mechanism of VVTT Infection Through Machine Learning and Transcriptome Analysis. <i>Int. J. Mol. Sci.</i> 2025, <i>26</i>, 1203.

International journal of molecular sciences·2026
Same author

Construction and Evaluation of a Chimeric Japanese Encephalitis Virus Vaccine Candidate Strain with Chaoyang Virus as the Backbone.

Vaccines·2026
Same author

Elucidating the Mechanism of VVTT Infection Through Machine Learning and Transcriptome Analysis.

International journal of molecular sciences·2025
Same author

Optimizing Yeast Homologous Recombination for Splicing Large Coronavirus Genome Fragments.

International journal of molecular sciences·2025
Same author

Uricase-Expressing Engineered Macrophages Alleviate Murine Hyperuricemia.

Biomedicines·2024
Same author

Optimization of PCA Error Correction Conditions to Improve Efficiency of Virus Genome De Novo Synthesis.

International journal of molecular sciences·2024
Same journal

Correction: Fukushima et al. Long-Term Immunogenicity of Rabies Pre-Exposure Prophylaxis in Japanese Adult Travelers: Comparison of Dosing Regimens. <i>Vaccines</i> 2025, <i>13</i>, 1169.

Vaccines·2026
Same journal

Access to Vaccines Among Asylum Seekers, Refugees, and Undocumented Migrants Across the Migratory Cycle in the European Union, European Economic Area, Switzerland and the United Kingdom: A Scoping Review.

Vaccines·2026
Same journal

Advances in Detection Methods for Human Respiratory Syncytial Virus Neutralizing Antibodies.

Vaccines·2026
Same journal

Insights from 25 Years of Measles and Measles-Rubella Vaccination Campaigns in the WHO African Region (2001-2025).

Vaccines·2026
Same journal

Post-Marketing Safety Surveillance of Influenza Vaccines in Anhui Province, China, 2016-2025.

Vaccines·2026
Same journal

Characteristics of Hypotonic-Hyporesponsive Episodes (HHEs) Following Childhood Vaccination: A 13-Year Analysis of Spontaneous Reports to the Dutch Pharmacovigilance Centre Lareb.

Vaccines·2026
See all related articles

Related Experiment Video

Updated: Sep 13, 2025

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.1K

Insect-Specific Flaviviruses Have Potential Applications as a Scaffold for Pathogenic Flavivirus Vaccines.

Jia-Zhen Cui1, Xiang-Hua Xiong1, Qing-Yang Wang1

  • 1Academy of Military Medical Sciences, Beijing 100850, China.

Vaccines
|July 30, 2025
PubMed
Summary
This summary is machine-generated.

Insect-specific flaviviruses (ISFVs) show promise as safe and effective vaccine scaffolds against pathogenic flaviviruses. Their unique inability to replicate in mammals offers a novel approach to developing next-generation vaccines.

Keywords:
host restrictioninsect-specific flaviviruspathogenic flavivirusvaccine developmentvaccine scaffold

More Related Videos

Zika Virus Specific Diagnostic Epitope Discovery
11:37

Zika Virus Specific Diagnostic Epitope Discovery

Published on: December 12, 2017

7.9K
Mosquito-Associated Virus Isolation from Field-Collected Mosquitoes
06:41

Mosquito-Associated Virus Isolation from Field-Collected Mosquitoes

Published on: August 31, 2022

2.0K

Related Experiment Videos

Last Updated: Sep 13, 2025

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.1K
Zika Virus Specific Diagnostic Epitope Discovery
11:37

Zika Virus Specific Diagnostic Epitope Discovery

Published on: December 12, 2017

7.9K
Mosquito-Associated Virus Isolation from Field-Collected Mosquitoes
06:41

Mosquito-Associated Virus Isolation from Field-Collected Mosquitoes

Published on: August 31, 2022

2.0K

Area of Science:

  • Virology
  • Vaccinology
  • Infectious Diseases

Background:

  • Pathogenic flaviviruses cause emerging infectious diseases, posing global health threats.
  • Current flavivirus vaccines face challenges like limited efficacy and virulence reversion.
  • Insect-specific flaviviruses (ISFVs) are highly homologous to pathogenic flaviviruses but do not replicate in mammals.

Purpose of the Study:

  • To review the biological characteristics and host restriction factors of ISFVs.
  • To summarize the current applications of ISFVs in vaccine development.
  • To identify challenges and future directions for ISFV-based vaccines.

Main Methods:

  • Literature review of ISFV biology and vaccine applications.
  • Analysis of host restriction mechanisms.
  • Evaluation of safety and efficacy data for ISFV-based vaccine candidates.

Main Results:

  • ISFVs possess unique biological properties and host restriction mechanisms.
  • ISFV-based vaccine candidates demonstrate significant safety and efficacy.
  • ISFVs represent a promising platform for novel flavivirus vaccine development.

Conclusions:

  • ISFVs offer a safe and effective alternative scaffold for flavivirus vaccine development.
  • Further research into ISFV biology and application is warranted.
  • ISFV-based vaccines hold potential for addressing unmet needs in flavivirus disease prevention.